• Home
  1. Home
  2. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study
Scientific article
English

Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study

ContributorsSimioni, Samanta; Cavassini, Matthias; Annoni, Gian-Maria; Métral, Mélanie; Iglesias, Katia; Rimbault Abraham, Aline; Jilek, Samantha; Calmy, Alexandraorcid; Muller, Hubertus; Fayet-Mello, Aurélie; Giacobini, Ezio; Hirschel, Bernard; Du Pasquier, Renaud A
Published inNeurology, vol. 80, no. 6, p. 553-560
Publication date2013
Abstract

To assess the efficacy and safety of rivastigmine for the treatment of HIV-associated neurocognitive disorders (HAND) in a cohort of long-lasting aviremic HIV+ patients.

Keywords
  • AIDS Dementia Complex/drug therapy
  • Cross-Over Studies
  • Double-Blind Method
  • Executive Function/drug effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuroprotective Agents/therapeutic use
  • Neuropsychological Tests
  • Phenylcarbamates/therapeutic use
  • Pilot Projects
Affiliation entities
Research groups
Citation (ISO format)
SIMIONI, Samanta et al. Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study. In: Neurology, 2013, vol. 80, n° 6, p. 553–560. doi: 10.1212/WNL.0b013e3182815497
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0028-3878
821views
1downloads

Technical informations

Creation03/12/2013 15:42:00
First validation03/12/2013 15:42:00
Update time14/03/2023 20:56:06
Status update14/03/2023 20:56:06
Last indexation30/10/2024 16:08:52
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack